Brazil Clears First Generic Copy of Novo Nordisk’s Ozempic Shot
Brazil approved the country’s first generic version of Novo Nordisk A/S’s Ozempic shot, opening the door to cheaper competition in one of the world’s fastest-growing markets for weight loss and diabetes drugs.
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.